Matthias Schlesner
0000-0002-5896-4086
Publication & Citation Trends
Publications
0 total
RBM39 shapes innate immunity through transcriptional and splicing control of key factors of the interferon response OA
Cited by 1
Semantic Scholar
Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia OA
Cited by 1
Semantic Scholar
OTHR-04. DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM OA
Cited by 0
Semantic Scholar
S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT OA
Cited by 0
Semantic Scholar
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking OA
Cited by 10
Semantic Scholar
S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q OA
Cited by 0
Semantic Scholar
Transcriptomic profiling does not refine mastocytosis diagnosis OA
Cited by 0
Semantic Scholar
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles OA
Cited by 73
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(109)
Single-cell and spatial transcriptomics
(38)
Epigenetics and DNA Methylation
(37)
Glioma Diagnosis and Treatment
(36)
Genetic factors in colorectal cancer
(33)
Affiliations
Broad Institute
Ontario Institute for Cancer Research
James S. McDonnell Foundation
Augsburg University
The University of Sydney
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.